We're buying more of this life sciences stock after an earnings-driven decline
The stock is under pressure in early trading due to uncertainty around the recovery in a key business.
KickT
0
44
Published Tue, Oct 24 20239:27 AM EDTUpdated An Hour Ago
.jpg&h=630&w=1200&q=100&v=f776164e2b&c=1)
